Mantle Cell Lymphoma

• CLINICAL_TRIALS withdrawal · 2025-02-03
  Clinical Trial Update: Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma [Phase 1]

  A Phase 1 clinical study evaluating duvortuxizumab plus ibrutinib in lymphomas has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2024-07-12
  Clinical Trial Update: Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy [Phase 1, Phase 2]

  A Phase 1/Phase 2 trial evaluating Interferon-Beta-1a (FP-1201) to prevent toxicities after CD19-directed CAR T-cell therapy has been withdr…

• CLINICAL_TRIALS withdrawal · 2024-04-25
  Clinical Trial Update: CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL [Phase 1]

  A Phase 1 trial investigating CpG-STAT3 siRNA CAS3/SS3 with localized radiation for relapsed/refractory B-cell non-Hodgkin lymphomas has bee…

• CLINICAL_TRIALS withdrawal · 2023-04-21
  Clinical Trial Update: A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]

  A Phase 3 trial combining Zilovertamab with Ibrutinib for relapsed or refractory mantle cell lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2022-04-29
  Clinical Trial Update: A Study of Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 3]

  Phase 3 study of parsaclisib with bendamustine and rituximab for newly diagnosed mantle cell lymphoma has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2017-12-02
  Clinical Trial Update: T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [Phase 1, Phase 2]

  A trial investigating T-regulatory cell and CD3-depleted double umbilical cord blood transplantation for hematologic malignancies has been w…

• CLINICAL_TRIALS withdrawal · 2017-04-05
  Clinical Trial Update: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation [Phase 2]

  This clinical trial update reports that the Phase 2 study of Sotrastaurin acetate for relapsed or refractory chronic lymphocytic leukemia, s…

• CLINICAL_TRIALS withdrawal · 2016-11-07
  Clinical Trial Update: A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002) [Phase 2]

  A Phase 2 trial of MK-4827 (niraparib) for mantle cell lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2016-08-11
  Clinical Trial Update: Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

  A Phase 1/Phase 2 study of Rituximab, Romidepsin, and Lenalidomide for recurrent or refractory B-cell non-Hodgkin lymphoma has been withdraw…

• CLINICAL_TRIALS withdrawal · 2016-05-13
  Clinical Trial Update: A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma [Phase 3]

  A Phase 3 trial evaluating acalabrutinib in combination with rituximab versus ibrutinib versus acalabrutinib in relapsed or refractory mantl…

• CLINICAL_TRIALS withdrawal · 2013-07-10
  Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma [Phase 2]

  Phase 2 trial of antineoplaston therapy for mantle cell lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-06-06
  Clinical Trial Update: Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating obatoclax mesylate in combination with rituximab and bendamustine hydrochloride for relapsed or refrac…

• CLINICAL_TRIALS withdrawal · 2012-12-06
  Clinical Trial Update: Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma

  A clinical trial evaluating combined CT colonography and PET imaging in Mantle cell lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2011-03-16
  Clinical Trial Update: Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL) [Phase 1, Phase 2]

  A Phase 1/2 clinical trial of bendamustine plus temsirolimus for relapsed or refractory mantle cell lymphoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2010-04-22
  Clinical Trial Update: Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma [Phase 1]

  A Phase 1 study of MDX-1411 for relapsed/refractory chronic lymphocytic leukemia or mantle cell lymphoma has been withdrawn from the trial p…